Edita Botonjic-Sehic

Pall Corporation
Sr. Principal R&D Scientist
Dr. Edita Botonjic-Sehic joined Pall Life Sciences in late 2016 as a senior principal R&D scientist. In this role, she is responsible for the strategic conceptualization and implementation of process analytical technology (PAT) and automation for the continuous bioprocessing portfolio; she brings more than 13 years of experience in spectroscopy and chemometrics for PAT and advanced analytical techniques to advancing this new concept.
<br><br>
Prior to joining Pall Life Sciences, Dr. Botonjic-Sehic was a member of the PAT team within GlaxoSmithKline’s program for API development and she also led a PAT team at TEVA Pharmaceuticals for drug product manufacturing, and was a principal investigator and program manager on several government-funded (DHS, TSWG, CTTSO) projects at Morpho Detection (formerly GE Homeland Security), where she specifically worked on the development of systems for trace and bulk materials detection.
<br><br>
Dr. Botonjic-Sehic completed her PhD in Analytical Chemistry at the University of Rhode Island after undergraduate studies at Assumption College in both chemistry and mathematics. She is a respected leader in her field and an accomplished author of numerous papers, and frequently delivers talks in the field of spectroscopy and chemometrics.